Synergistic cytotoxicity and apoptosis induced in human cholangiocarcinoma cell lines by a combined treatment with tumor necrosis factor-alpha (TNF-α) and triptolide

Asian Pacific Journal of Allergy and Immunology

Volumn 20, Issue 3, 2002, Pages 167-173

  Panichakul, Tasanee ^a   Wanun, Thiwaree ^a   Reutrakul, Vichai ^b   Sirisinha, Stitaya ^a,b  

^a Laboratory of Immunology   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ACETYLASPARTYLGLUTAMYLVALYLASPARTYL CHLOROMETHYL KETONE; CASPASE 3; ENZYME INHIBITOR; EPOXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOTHERAPY; STAINING; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; IMMUNOBLOTTING; PHENANTHRENES; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036771378     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sirisinha S, Petmir S, Utaisincharoen P, Tengchaisri T. Cholangiocarcinoma. Asian J Surg 1996; 19: 198-206.
2. Sampson LK, Vickers SM, Ying W, Phillips JO. Tamoxifen-mediated growth inhibition of human cholangiocarcinoma. Cancer Res 1997; 57: 1743-9.
3. Jaiswal M, LaRusso NF, Burgart LJ, Gores G J. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by nitric oxide-dependent mechanism. Cancer Res 2000; 60: 184-90.
4. Todoroki T. Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepato Gastroenterology 2000; 47: 644-9.
5. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281: 1305-25.
6. Utaisincharoen P, Ubol S, Tangthawornchaikul N, Chaisuriya P, Sirisinha S. Binding of tumour necrosis factor-alpha (TNF-α) to TNF-RI induces caspase(s)-dependent apoptosis in human cholangiocarcinoma cell lines. Clin Exp Immunol 1999; 116: 41-7.
7. Shamon LA, Pezzuto JM, Graves JM, Mehta RR, Wangcharoentrakul S, Sangsuwan R, Chaichana S, Tuchinda P, Cleason P, Reutrakul V. Evaluation of the mutagenic, cytotoxic and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett 1996; 11: 113-7.
8. Tengchaisri T, Chawengkirttikul R, Rachaphaew N, Reutrakul V, Sangsuwan R, Sirisinha S. Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamster. Cancer Lett 1998; 133: 169-75.
9. Sirisinha S, Tengchaisri T, Boonpucknavig S, Prempracha N, Ratanarapee S, Pausawasdi A. Establishment and characterization of cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer. Asian Pacific J Allergy Immunol 1991; 9: 153-7.
10. Sripa B, Leungwattanawanit S, Bhudhisawasdi B, Puapairoj A, Aranyanart C, Kanla P, Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). Hepato Gastroenterol 2002; (in press).
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
12. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets; Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
13. Lee KY, Chang W, Qiu D, Kao PN, Rosen GD. PG490 (triptolide) cooperates with tumor necrosis factor-α to induce apoptosis in tumor cells. J Biol Chem 1999; 274: 13451-5.